BSE Live
Oct 31, 16:01Prev. Close
437.85
Open Price
440.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:54Prev. Close
439.45
Open Price
440.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Venus Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 638.87 | 565.21 | 535.53 | 575.18 | 507.00 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 638.87 | 565.21 | 535.53 | 575.18 | 507.00 | |
| Total Operating Revenues | 639.46 | 575.21 | 537.66 | 575.18 | 514.62 | |
| Other Income | 20.78 | 11.32 | 10.17 | 8.43 | 17.76 | |
| Total Revenue | 660.24 | 586.53 | 547.84 | 583.61 | 532.39 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 348.82 | 344.15 | 317.28 | 372.78 | 344.04 | |
| Purchase Of Stock-In Trade | 25.04 | 13.07 | 5.16 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 17.01 | 14.59 | 10.17 | 9.85 | 7.74 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.93 | -5.00 | 14.26 | 3.19 | -7.36 | |
| Employee Benefit Expenses | 72.24 | 62.13 | 51.95 | 43.75 | 35.89 | |
| Finance Costs | 0.00 | 0.00 | 0.00 | 0.00 | 12.73 | |
| Depreciation And Amortisation Expenses | 21.62 | 25.55 | 31.37 | 32.58 | 34.28 | |
| Other Expenses | 105.42 | 85.38 | 77.31 | 76.80 | 87.44 | |
| Total Expenses | 591.08 | 539.88 | 507.51 | 538.94 | 514.77 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 69.16 | 46.65 | 40.33 | 44.67 | 17.62 | |
| Exceptional Items | 9.91 | 0.00 | 0.00 | 0.00 | 23.44 | |
| Profit/Loss Before Tax | 79.08 | 46.65 | 40.33 | 44.67 | 41.06 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 18.93 | 11.74 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 4.65 | 3.93 | 11.36 | -4.32 | -13.21 | |
| Tax For Earlier Years | 2.93 | 0.48 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 26.51 | 16.15 | 11.36 | -4.32 | -13.21 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 52.56 | 30.50 | 28.96 | 48.99 | 54.27 | |
| Profit/Loss From Continuing Operations | 52.56 | 30.50 | 28.96 | 48.99 | 54.27 | |
| Profit/Loss For The Period | 52.56 | 30.50 | 28.96 | 48.99 | 54.27 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 39.32 | 22.82 | 21.67 | 37.12 | 43.97 | |
| Diluted EPS (Rs.) | 39.32 | 22.82 | 21.67 | 37.12 | 43.97 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y